KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis
NYSE:PHG - New York Stock Exchange, Inc. - US5004723038 - Currency: USD
Overall PHG gets a fundamental rating of 4 out of 10. We evaluated PHG against 191 industry peers in the Health Care Equipment & Supplies industry. PHG has a bad profitability rating. Also its financial health evaluation is rather negative. PHG has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
PHG had positive earnings in the past year.
PHG had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PHG reported negative net income in multiple years.
Of the past 5 years PHG 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -1.43%, PHG is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
The Return On Equity of PHG (-3.54%) is better than 69.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.54% | ||
| ROIC | N/A |
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHG's Operating Margin has declined in the last couple of years.
PHG has a worse Gross Margin (41.56%) than 65.79% of its industry peers.
In the last couple of years the Gross Margin of PHG has remained more or less at the same level.
PHG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.56% |
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
2. Health
2.1 Basic Checks
PHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PHG has less shares outstanding
The number of shares outstanding for PHG has been increased compared to 5 years ago.
Compared to 1 year ago, PHG has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.65, we must say that PHG is in the distress zone and has some risk of bankruptcy.
PHG has a Altman-Z score (1.65) which is in line with its industry peers.
PHG has a debt to FCF ratio of 7.27. This is a slightly negative value and a sign of low solvency as PHG would need 7.27 years to pay back of all of its debts.
The Debt to FCF ratio of PHG (7.27) is better than 73.16% of its industry peers.
PHG has a Debt/Equity ratio of 0.60. This is a neutral value indicating PHG is somewhat dependend on debt financing.
PHG's Debt to Equity ratio of 0.60 is on the low side compared to the rest of the industry. PHG is outperformed by 65.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 7.27 | ||
| Altman-Z | 1.65 |
ROIC/WACCN/A
WACC6.08%
2.3 Liquidity
PHG has a Current Ratio of 1.16. This is a normal value and indicates that PHG is financially healthy and should not expect problems in meeting its short term obligations.
PHG has a worse Current ratio (1.16) than 86.84% of its industry peers.
A Quick Ratio of 0.74 indicates that PHG may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.74, PHG is doing worse than 88.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
PHG shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.65%.
The Earnings Per Share has been decreasing by -2.67% on average over the past years.
Looking at the last year, PHG shows a decrease in Revenue. The Revenue has decreased by -2.65% in the last year.
Measured over the past years, PHG shows a small growth in Revenue. The Revenue has been growing by 0.05% on average per year.
EPS 1Y (TTM)3.65%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%-3.03%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-2.1%
3.2 Future
The Earnings Per Share is expected to grow by 15.34% on average over the next years. This is quite good.
PHG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.64% yearly.
EPS Next Y14.33%
EPS Next 2Y11.67%
EPS Next 3Y12.92%
EPS Next 5Y15.34%
Revenue Next Year-1.9%
Revenue Next 2Y1.25%
Revenue Next 3Y2.36%
Revenue Next 5Y3.64%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.39, PHG is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 86.84% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.47, PHG is valued a bit cheaper.
A Price/Forward Earnings ratio of 16.94 indicates a correct valuation of PHG.
Based on the Price/Forward Earnings ratio, PHG is valued cheaply inside the industry as 87.37% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of PHG to the average of the S&P500 Index (92.74), we can say PHG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.39 | ||
| Fwd PE | 16.94 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHG is valued a bit cheaper than 72.11% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 89.47% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.65 | ||
| EV/EBITDA | 31.14 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PHG's earnings are expected to grow with 12.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.42
PEG (5Y)N/A
EPS Next 2Y11.67%
EPS Next 3Y12.92%
5. Dividend
5.1 Amount
PHG has a Yearly Dividend Yield of 4.15%, which is a nice return.
Compared to an average industry Dividend Yield of 1.58, PHG pays a better dividend. On top of this PHG pays more dividend than 100.00% of the companies listed in the same industry.
PHG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
5.2 History
The dividend of PHG decreases each year by -65.46%.
PHG has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-65.46%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of PHG are negative and hence is the payout ratio. PHG will probably not be able to sustain this dividend level.
DP-0.48%
EPS Next 2Y11.67%
EPS Next 3Y12.92%
KONINKLIJKE PHILIPS NVR- NY
NYSE:PHG (2/4/2025, 8:04:00 PM)
After market: 26.91 0 (0%)26.91
+0.12 (+0.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.12%
Inst Owner Change-0.89%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap25.29B
Analysts71.85
Price Target30.51 (13.38%)
Short Float %0.23%
Short Ratio3.16
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
Yearly Dividend0
Dividend Growth(5Y)-65.46%
DP-0.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.06%
Min EPS beat(2)-13.15%
Max EPS beat(2)-6.96%
EPS beat(4)1
Avg EPS beat(4)-8.37%
Min EPS beat(4)-25.88%
Max EPS beat(4)12.53%
EPS beat(8)3
Avg EPS beat(8)19.85%
EPS beat(12)3
Avg EPS beat(12)2.62%
EPS beat(16)7
Avg EPS beat(16)5.54%
Revenue beat(2)0
Avg Revenue beat(2)-2.71%
Min Revenue beat(2)-2.95%
Max Revenue beat(2)-2.46%
Revenue beat(4)0
Avg Revenue beat(4)-3.39%
Min Revenue beat(4)-7.41%
Max Revenue beat(4)-0.75%
Revenue beat(8)2
Avg Revenue beat(8)-0.89%
Revenue beat(12)2
Avg Revenue beat(12)-1.44%
Revenue beat(16)2
Avg Revenue beat(16)-3.44%
PT rev (1m)1.44%
PT rev (3m)-6.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-5.05%
EPS NY rev (3m)-5.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-1.08%
Revenue NY rev (3m)-1.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.39 | ||
| Fwd PE | 16.94 | ||
| P/S | 1.36 | ||
| P/FCF | 21.65 | ||
| P/OCF | 13.68 | ||
| P/B | 2.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 31.14 |
EPS(TTM)1.32
EY4.91%
EPS(NY)1.59
Fwd EY5.9%
FCF(TTM)1.24
FCFY4.62%
OCF(TTM)1.97
OCFY7.31%
SpS19.82
BVpS12.99
TBVpS-1.58
PEG (NY)1.42
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.54% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.56% | ||
| FCFM | 6.27% |
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
F-Score5
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 7.27 | ||
| Debt/EBITDA | 7.18 | ||
| Cap/Depr | 51.64% | ||
| Cap/Sales | 3.66% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 181.09% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | 1.65 |
F-Score5
WACC6.08%
ROIC/WACCN/A
Cap/Depr(3y)53.02%
Cap/Depr(5y)58.22%
Cap/Sales(3y)4.17%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.65%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%-3.03%
EPS Next Y14.33%
EPS Next 2Y11.67%
EPS Next 3Y12.92%
EPS Next 5Y15.34%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-2.1%
Revenue Next Year-1.9%
Revenue Next 2Y1.25%
Revenue Next 3Y2.36%
Revenue Next 5Y3.64%
EBIT growth 1Y20.11%
EBIT growth 3Y-39.56%
EBIT growth 5Y-26.36%
EBIT Next Year69.31%
EBIT Next 3Y25.78%
EBIT Next 5YN/A
FCF growth 1Y-60.7%
FCF growth 3Y-2.55%
FCF growth 5Y0.39%
OCF growth 1Y-51.1%
OCF growth 3Y-5.06%
OCF growth 5Y-1.42%